Vital Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 9.41 Cr
- Company Age 26 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 28.08 Cr
- Satisfied Charges ₹ 45.00 Cr
- Revenue Growth -13.67%
- Profit Growth -14.40%
- Ebitda -17.13%
- Net Worth 19.29%
- Total Assets 24.56%
About Vital Therapeutics
Vital Therapeutics Private Limited (VTPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 August 1998 and has a history of 26 years and six months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.41 Cr.
The company currently has active open charges totaling ₹28.08 Cr. The company has closed loans amounting to ₹45.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ramesh Sarvisetty and Venugopal Sarvisetty serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24110TG1998PTC029876
- Company No.
029876
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Aug 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Vital Therapeutics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venugopal Sarvisetty  | Managing Director | 04-Aug-1998 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramesh Sarvisetty | Whole-Time Director | 04-Aug-1998 | Current |
Financial Performance of Vital Therapeutics.
Vital Therapeutics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.67% decrease. The company also saw a substantial fall in profitability, with a 14.4% decrease in profit. The company's net worth Soared by an impressive increase of 19.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vital Therapeutics?
In 2023, Vital Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vital Therapeutics And Formulations Private LimitedRamesh Sarvisetty and Venugopal Sarvisetty are mutual person
Pellsys Pharma Private LimitedRamesh Sarvisetty and Venugopal Sarvisetty are mutual person
- Parakite Builders Private Limited
Ramesh Sarvisetty and Venugopal Sarvisetty are mutual person
- Mondo Builders Private Limited
Ramesh Sarvisetty and Venugopal Sarvisetty are mutual person
- Housz Buildtech Llp
Venugopal Sarvisetty is a mutual person
Charges (Loans)
₹28.08 Cr
₹45.00 Cr
Charges Breakdown by Lending Institutions
- Others : 26.78 Cr
- Axis Bank Limited : 1.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Oct 2023 | Others | ₹15.00 Cr | Open |
| 21 Sep 2023 | Axis Bank Limited | ₹5.00 M | Open |
| 14 Nov 2022 | Axis Bank Limited | ₹8.00 M | Open |
| 19 May 2022 | Others | ₹10.00 Cr | Open |
| 27 Sep 2021 | Others | ₹8.50 M | Open |
How Many Employees Work at Vital Therapeutics?
Unlock and access historical data on people associated with Vital Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vital Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vital Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
